NASDAQ:DVAX

Dynavax Technologies News Headlines

$10.07
0.00 (0.00 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.58
Now: $10.07
$10.08
50-Day Range
$8.16
MA: $9.52
$10.99
52-Week Range
$2.89
Now: $10.07
$12.44
Volume1.69 million shs
Average Volume5.64 million shs
Market Capitalization$1.14 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.34

Headlines

Dynavax Technologies (NASDAQ DVAX) News Headlines Today

SourceHeadline
Dynavax (DVAX) Up on Positive COVID-19 Vaccine Study Data (Revised)Dynavax (DVAX) Up on Positive COVID-19 Vaccine Study Data (Revised)
finance.yahoo.com - April 9 at 12:20 PM
Dynavax’s CpG 1018 Used In Valneva’s COVID-19 Vaccine Reports Positive ResultsDynavax’s CpG 1018 Used In Valneva’s COVID-19 Vaccine Reports Positive Results
finance.yahoo.com - April 6 at 2:52 PM
Dynavax Technologies (NASDAQ:DVAX) Shares Gap Up to $9.84Dynavax Technologies (NASDAQ:DVAX) Shares Gap Up to $9.84
americanbankingnews.com - April 6 at 11:02 AM
Valneva Reports Positive Results From Trial Of COVID-19 Vaccine Candidate Using Dynavaxs AdjuvantValneva Reports Positive Results From Trial Of COVID-19 Vaccine Candidate Using Dynavax's Adjuvant
markets.businessinsider.com - April 6 at 9:40 AM
Positive Phase 1/2 Results for Valnevas Inactivated COVID-19 Vaccine Candidate Using Dynavaxs CpG 1018™ AdjuvantPositive Phase 1/2 Results for Valneva's Inactivated COVID-19 Vaccine Candidate Using Dynavax's CpG 1018™ Adjuvant
finance.yahoo.com - April 6 at 9:40 AM
French vaccine maker Valneva to launch Phase 3 trial of COVID vaccine its making with Dynavax after positive resultsFrench vaccine maker Valneva to launch Phase 3 trial of COVID vaccine it's making with Dynavax after positive results
finance.yahoo.com - April 6 at 9:40 AM
-$0.02 Earnings Per Share Expected for Dynavax Technologies Co. (NASDAQ:DVAX) This Quarter-$0.02 Earnings Per Share Expected for Dynavax Technologies Co. (NASDAQ:DVAX) This Quarter
americanbankingnews.com - March 28 at 10:40 PM
Clover, Dynavax Dose First Patient In Phase 2/3 Trial Of Adjuvanted COVID-19 Vaccine CandidateClover, Dynavax Dose First Patient In Phase 2/3 Trial Of Adjuvanted COVID-19 Vaccine Candidate
nasdaq.com - March 24 at 2:16 PM
Dynavax Technologies (NASDAQ:DVAX) Shares Gap Up to $10.12Dynavax Technologies (NASDAQ:DVAX) Shares Gap Up to $10.12
americanbankingnews.com - March 24 at 11:38 AM
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine CandidateClover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
finance.yahoo.com - March 24 at 9:15 AM
Clover Biopharmaceuticals and Dynavax Announce...Clover Biopharmaceuticals and Dynavax Announce...
benzinga.com - March 24 at 4:14 AM
Dynavax Technologies (NASDAQ:DVAX) Shares Up 5.3%Dynavax Technologies (NASDAQ:DVAX) Shares Up 5.3%
americanbankingnews.com - March 22 at 1:42 PM
Breakeven Is Near for Dynavax Technologies Corporation (NASDAQ:DVAX)Breakeven Is Near for Dynavax Technologies Corporation (NASDAQ:DVAX)
finance.yahoo.com - March 19 at 9:37 AM
Dynavax Technologies (NASDAQ:DVAX) Trading Down 5.1%Dynavax Technologies (NASDAQ:DVAX) Trading Down 5.1%
americanbankingnews.com - March 18 at 7:32 PM
Dynavax Technologies: A Surprising COVID-19 PlayDynavax Technologies: A Surprising COVID-19 Play
seekingalpha.com - March 1 at 7:09 PM
Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences ConferenceDynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference
finance.yahoo.com - March 1 at 6:50 PM
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q4 2020 Results - Earnings Call TranscriptDynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 9:50 AM
Why Dynavax Technologies Is Trading Higher TodayWhy Dynavax Technologies Is Trading Higher Today
benzinga.com - February 26 at 2:09 PM
Dynavaxs Q4 Results Show Its Not Just About Heplisav-B AnymoreDynavax's Q4 Results Show It's Not Just About Heplisav-B Anymore
finance.yahoo.com - February 26 at 9:08 AM
Dynavax Technologies (DVAX) Q4 2020 Earnings Call TranscriptDynavax Technologies (DVAX) Q4 2020 Earnings Call Transcript
fool.com - February 26 at 5:54 AM
Dynavax Announces Fourth Quarter and Full Year 2020 Financial ResultsDynavax Announces Fourth Quarter and Full Year 2020 Financial Results
marketwatch.com - February 25 at 7:38 PM
Has Dynavax Technologies (DVAX) Outpaced Other Medical Stocks This Year?Has Dynavax Technologies (DVAX) Outpaced Other Medical Stocks This Year?
nasdaq.com - February 24 at 1:35 PM
Earnings Preview for Dynavax TechnologiesEarnings Preview for Dynavax Technologies
finance.yahoo.com - February 24 at 1:35 PM
Dynavax’s Hepatitis B Vaccine Authorized In Europe; Shares Rise 6%Dynavax’s Hepatitis B Vaccine Authorized In Europe; Shares Rise 6%
finance.yahoo.com - February 21 at 7:26 AM
Why Dynavax Stock Jumped TodayWhy Dynavax Stock Jumped Today
finance.yahoo.com - February 19 at 6:12 PM
Dynavax Announces European Commission Marketing Authorization for HEPLISAV B®, a 2 Dose Adult Hepatitis B Adjuvanted VaccineDynavax Announces European Commission Marketing Authorization for HEPLISAV B®, a 2 Dose Adult Hepatitis B Adjuvanted Vaccine
finance.yahoo.com - February 19 at 1:12 PM
Dynavax to Present at the Cowen 41st Annual Health Care ConferenceDynavax to Present at the Cowen 41st Annual Health Care Conference
finance.yahoo.com - February 16 at 5:06 PM
Moving Average Crossover Alert: Dynavax (DVAX)Moving Average Crossover Alert: Dynavax (DVAX)
nasdaq.com - February 16 at 12:06 PM
Dynavax to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 25, 2021Dynavax to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 25, 2021
finance.yahoo.com - February 11 at 5:00 PM
Dong Yu, Ph.D., Joins Dynavax as Senior Vice President of Vaccine ResearchDong Yu, Ph.D., Joins Dynavax as Senior Vice President of Vaccine Research
finance.yahoo.com - February 8 at 7:52 PM
Dynavax, Serum Institute Start Phase 1 Trial For Tdap Booster VaccineDynavax, Serum Institute Start Phase 1 Trial For Tdap Booster Vaccine
finance.yahoo.com - February 4 at 5:00 PM
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - February 4 at 5:00 PM
Dynavax and Serum Institute of India Announce First Participant Dosed in a Phase 1 Clinical Trial Evaluating an Improved Tdap Vaccine Adjuvanted with CpG 1018Dynavax and Serum Institute of India Announce First Participant Dosed in a Phase 1 Clinical Trial Evaluating an Improved Tdap Vaccine Adjuvanted with CpG 1018
finance.yahoo.com - February 4 at 11:59 AM
Is Dynavax Stock Still Worth Buying After Its 60%-Plus Rally? Analyst Weighs InIs Dynavax Stock Still Worth Buying After Its 60%-Plus Rally? Analyst Weighs In
finance.yahoo.com - February 2 at 8:00 PM
Need To Know: Analysts Are Much More Bullish On Dynavax Technologies Corporation (NASDAQ:DVAX)Need To Know: Analysts Are Much More Bullish On Dynavax Technologies Corporation (NASDAQ:DVAX)
finance.yahoo.com - February 2 at 9:25 AM
Notable Monday Option Activity: UPS, DVAX, BCRXNotable Monday Option Activity: UPS, DVAX, BCRX
nasdaq.com - February 1 at 5:22 PM
Why Dynavax Stock Is Skyrocketing TodayWhy Dynavax Stock Is Skyrocketing Today
finance.yahoo.com - February 1 at 5:22 PM
Thinking about buying stock in First Majestic Silver, Dynavax Technologies, AMC Entertainment, McEwen Mining, or Sorrento Therapeutics?Thinking about buying stock in First Majestic Silver, Dynavax Technologies, AMC Entertainment, McEwen Mining, or Sorrento Therapeutics?
marketwatch.com - February 1 at 12:22 PM
Clover, Dynavax Plan To Initiate Phase 2/3 Efficacy Trial Of Adjuvanted COVID-19 Vaccine CandidateClover, Dynavax Plan To Initiate Phase 2/3 Efficacy Trial Of Adjuvanted COVID-19 Vaccine Candidate
nasdaq.com - February 1 at 12:22 PM
Why Dynavax Shares Are Rallying TodayWhy Dynavax Shares Are Rallying Today
markets.businessinsider.com - February 1 at 12:22 PM
Viela Bio, Dynavax Technologies leads healthcare gainers; Matinas BioPharma, Concert Pharmaceuticals among major losersViela Bio, Dynavax Technologies leads healthcare gainers; Matinas BioPharma, Concert Pharmaceuticals among major losers
seekingalpha.com - February 1 at 11:18 AM
Dynavax and CEPI Announce $99 Million in Funding for CpG 1018 Adjuvant Manufacturing to Support the Global COVID-19 ResponseDynavax and CEPI Announce $99 Million in Funding for CpG 1018 Adjuvant Manufacturing to Support the Global COVID-19 Response
finance.yahoo.com - February 1 at 7:22 AM
Dynavax Announces Exercise of Option to Reserve Additional CpG 1018 to Produce 40 Million Doses of Valnevas Inactivated, Adjuvanted COVID-19 Vaccine Candidate for the UK GovernmentDynavax Announces Exercise of Option to Reserve Additional CpG 1018 to Produce 40 Million Doses of Valneva's Inactivated, Adjuvanted COVID-19 Vaccine Candidate for the UK Government
finance.yahoo.com - February 1 at 7:22 AM
Dynavax Technologies CorpDynavax Technologies Corp
bloomberg.com - January 28 at 8:03 PM
Medigen Vaccine Biologics COVID-19 Vaccine Adjuvanted with Dynavaxs CpG 1018 Announces First Participant Dosed in Phase 2 Clinical Trial in TaiwanMedigen Vaccine Biologics COVID-19 Vaccine Adjuvanted with Dynavax's CpG 1018 Announces First Participant Dosed in Phase 2 Clinical Trial in Taiwan
finance.yahoo.com - January 25 at 8:34 AM
Dynavax Appoints Kelly MacDonald as Chief Financial OfficerDynavax Appoints Kelly MacDonald as Chief Financial Officer
finance.yahoo.com - January 20 at 4:40 PM
Why Dynavax Stock Is Vaulting Higher TodayWhy Dynavax Stock Is Vaulting Higher Today
finance.yahoo.com - January 7 at 2:45 PM
Dynavax Announces Final Immunogenicity and Interim Safety Results from Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing HemodialysisDynavax Announces Final Immunogenicity and Interim Safety Results from Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
finance.yahoo.com - January 7 at 9:45 AM
DVAX Jan 2021 17.000 putDVAX Jan 2021 17.000 put
sg.finance.yahoo.com - January 6 at 11:30 PM
Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2021 ConferenceDynavax to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
finance.yahoo.com - January 6 at 6:29 PM
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.